NECLIFENSENectar Lifesciences Limited· PharmaceuticalsLowNeutral
Announced Wed, 8 Apr · 13:21 IST

Nectar Lifesciences Limited has informed the Exchange about General Updates

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.3%1-day move
₹10.01
prior close
₹10.79
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+1.0+0.9+7.3+17.4+19.4+23.3+23.9+23.4+24.4+43.7+17.1+11.4
Up moveDown movePending
AI summary

Nectar Lifesciences has launched the second phase of its 'Saksham Niveshak' shareholder outreach campaign from April 1, 2026, to July 9, 2026, under IEPF Authority guidelines. The campaign aims to help investors update KYC details including bank account mandates, nominee registration, and contact information. It also encourages shareholders to claim unpaid or unclaimed dividends for Final Dividend 2018-19 and 2019-20 before they get transferred to the IEPF Authority. Investors can contact RTA KFin Technologies Limited or the company directly. Dividends unpaid for seven consecutive years are mandatorily transferred to IEPF along with corresponding shares.

Likely market impact

Shareholders with unclaimed dividends or incomplete KYC records should act promptly during the campaign to safeguard their entitlements. This is a routine administrative communication with no direct impact on the company's financial performance or stock price.